Our Pipeline
Eporgen has a rich pipeline of new therapeutic agents...
...as well as technologies, diagnostics and other biotech products in advanced development phase.
Bridge projects
|
New molecular target in oncology (University of Philadelphia)
New therapeutic protein for the treatment of pediatric infections (CNR)
New diagnostic kit for the detection of hidden caries (University of Torino)
|
- 6-8 months to reach "proof of concept"
- Intellectual Property already secured
- Very limited investment
- New start-up at the end of the feasibility study
|
Eporgen Venture also invests into feasibility studies to verify the viability of interesting ideas (pre-seed financing).
|
